Pressurised intraperitoneal aerosol chemotherapy (PIPAC): the first Australian experience [0.03%]
腹腔内喷雾化疗（PIPAC）的首次澳大利亚经验
Katarina Foley,Jessica Reid,Suzanne Edwards et al.
Katarina Foley et al.
Objectives: Pressurised intraperitoneal aerosol chemotherapy (PIPAC) is a novel surgical technique for patients with peritoneal metastases not amenable to curative treatment. PIPAC delivers pressurised aerosolised chemoth...
Aras Emre Canda,Semra Demirli Atici,Evren Kadioglu et al.
Aras Emre Canda et al.
Patient-specific 3D-tissue slices from peritoneal metastases - An in vitro model for individual susceptibility analysis [0.03%]
来自腹膜转移的患者特异性三维组织切片-用于个体易感性分析的体外模型
Christian Etzold,Orestis Lyros,Matthias Mehdorn et al.
Christian Etzold et al.
Objectives: The prognosis of patients with peritoneal metastases (PM) is poor, and these patients have a brief overall survival. Most patients with advanced PM receive palliative therapy to maintain their quality of life....
Can inter-observer consistency be achieved in the laparoscopic assessment of the peritoneal carcinomatosis index score in peritoneal metastasis? A pilot study [0.03%]
观察者之间的一致性能在腹腔镜评估腹膜转移癌的腹膜癌负荷评分中实现吗？一项初步研究
Audrey Astruc,Valérie Seegers,Frederic Dumont et al.
Audrey Astruc et al.
Objectives: The main prognostic factor for peritoneal metastasis (PM) is the complete resection of the disease during cytoreductive surgery. Accurate patient selection is therefore essential for determining eligibility fo...
Questioning the role of HIPEC in patients with granulosa cell ovarian tumours [0.03%]
腹膜腔热灌注化疗在颗粒细胞瘤患者中作用的再评估
Christos Iavazzo,Ioannis D Gkegkes
Christos Iavazzo
Implementation and evaluation of Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) for the treatment of patients with malignant pleural effusion: study protocol for the Danish phase-I PITAC-OPC5 study [0.03%]
加压胸腔内喷雾化疗（PITAC）治疗恶性胸水患者的实施及评价：丹麦一期PITAC-OPC5研究方案
Pernille Schjødt Hansen,Martin Graversen,Sönke Detlefsen et al.
Pernille Schjødt Hansen et al.
Objectives: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) is a minimally invasive cancer-directed therapy for patients with malignant pleural effusion (MPE) and/or pleural metastasis (PLM). PITAC is based on Pres...
Reply to: Questioning the role of HIPEC in patients with granulosa cell ovarian tumours [0.03%]
关于颗粒细胞卵泡膜细胞肿瘤患者HIPEC作用的疑问的回答
Luis Felipe Falla-Zuniga,Armando Sardi,Mary Caitlin King et al.
Luis Felipe Falla-Zuniga et al.
Extent of peritoneal metastases from colorectal cancer is not associated with changes in thrombin generation or fibrinolysis [0.03%]
腹膜转移性结直肠癌患者凝血和纤溶功能变化检测指标的研究
Mikkel Lundbech,Andreas Engel Krag,Lene Hjerrild Iversen et al.
Mikkel Lundbech et al.
Objectives: Cancer cells can activate coagulation and inhibit fibrinolysis. The aim was to investigate the association between the burden of peritoneal metastases from colorectal cancer (PM-CRC) and biomarkers reflecting ...
Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) directed therapy of patients with malignant pleural effusion and pleural metastasis [0.03%]
恶性胸水和胸膜转移癌的加压胸腔内喷雾化疗(PITAC)治疗
Pernille Schjødt Hansen,Martin Graversen,Sönke Detlefsen et al.
Pernille Schjødt Hansen et al.
Objectives: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) has been suggested as a new therapy for patients with malignant pleural effusion (MPE) and/or pleural metastasis (PLM). The patients have a poor prognosis...